Sharad Kumar Dass, MD
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 9 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Santa Clara Valley Medical Center · 555916. That is not proof they admit you there this week.
Plans that list them
28 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dass’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A70405 · Current
Licensed to practise in California · since 1999 · expires 2027-12-31 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$378,319
Medicare paid this office $378,319 for 445 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 257 | $63,089 | $126 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 17 | $45,643 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $41,735 | $114 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 89 | $35,768 | $50 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 58 | $25,724 | $40 |
See all 25 services
| Return visit (30+ min) | 257 | $63,089 | $126 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 17 | $45,643 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 87 | $41,735 | $114 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 89 | $35,768 | $50 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 58 | $25,724 | $40 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 62 | $24,235 | $51 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $20,857 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 99 | $18,912 | $166 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 51 | $17,084 | $57 |
| Long return visit (40+ min) | 62 | $16,332 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $12,258 | $76 |
| New patient visit (45+ min) | 81 | $12,236 | $151 |
| Sleep study including heart rate, breathing, airflow, and effort | 61 | $6,545 | $98 |
| New patient visit (60+ min) | 28 | $6,229 | $222 |
| Test to examine how well the lungs exchange gases | 66 | $4,196 | $64 |
| Test to determine lung volumes using sensors | 69 | $4,167 | $60 |
| Sleep study including heart rate, breathing, and sleep time | 18 | $3,431 | $156 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 64 | $2,566 | $40 |
| Short return visit (20+ min) | 21 | $1,928 | $84 |
| Test for exercise-induced lung stress | 38 | $1,399 | $36 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,234 | $112 |
| Test to measure largest amount of air breathed in an out | 62 | $1,028 | $17 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 38 | $1,026 | $26 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 22 | $518 | $24 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 11 | $159 | $11 |
Who their Medicare patients are
445 Original Medicare patients in 2024. Average age 77 · Under 65 7% · 85 and older 23% · Women 48% · Also on Medicaid 39% · Health risk score 2.00. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 45% · Chronic kidney disease 40% · Heart failure 39% · COPD 38% · Atrial fibrillation 32% · Depression 20% · Cancer 17% · Dementia 15% · Stroke 15%.
The office billed $1,104,597, Medicare allowed $483,739 and paid $378,319; for 4,648 services of 49 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 445 | 4,648 | 77 | 2.00 | $1,104,597 | $378,319 |
| 2023 | 486 | 5,928 | 78 | 2.05 | $1,203,002 | $380,962 |
| 2022 | 443 | 4,764 | 77 | 2.27 | $1,115,338 | $347,565 |
| 2021 | 507 | 3,371 | 77 | 2.40 | $893,062 | $288,642 |
| 2020 | 521 | 2,304 | 76 | 2.48 | $1,023,009 | $237,805 |
| 2019 | 473 | 2,439 | 77 | 2.66 | $988,374 | $260,857 |
| 2018 | 486 | 2,508 | 76 | 2.77 | $990,671 | $284,696 |
| 2017 | 851 | 4,568 | 76 | 2.61 | $1,715,447 | $471,373 |
| 2016 | 574 | 3,139 | 74 | 2.50 | $1,006,293 | $331,975 |
| 2015 | 474 | 2,632 | 76 | 2.70 | $569,988 | $304,114 |
| 2014 | 490 | 2,995 | 75 | 2.47 | $800,350 | $369,419 |
| 2013 | 498 | 2,832 | 76 | 2.68 | $708,371 | $351,970 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 17 | $49,195 | $95 |
| Return visit (30+ min) | 223 | $48,367 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 117 | $43,995 | $107 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 73 | $27,997 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 135 | $22,594 | $154 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 57 | $22,204 | $36 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $22,033 | $139 |
| Long return visit (40+ min) | 76 | $21,344 | $167 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 59 | $20,068 | $45 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 61 | $18,654 | $53 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 103 | $17,005 | $71 |
| Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 56 | $14,018 | $12 |
| New patient visit (45+ min) | 77 | $11,041 | $143 |
| Sleep study including heart rate, breathing, airflow, and effort | 71 | $7,418 | $89 |
| New patient visit (60+ min) | 30 | $5,991 | $200 |
| Short return visit (20+ min) | 44 | $3,874 | $81 |
| Test to examine how well the lungs exchange gases | 64 | $3,731 | $57 |
| Test to determine lung volumes using sensors | 64 | $3,520 | $53 |
| Hospital discharge day management, more than 30 minutes | 29 | $3,070 | $102 |
| Critical care, first 30-74 minutes | 12 | $2,631 | $188 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 11 | $2,500 | $167 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 57 | $2,193 | $37 |
| Test for exercise-induced lung stress | 31 | $1,078 | $33 |
| Test to measure largest amount of air breathed in an out | 61 | $901 | $14 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 31 | $795 | $24 |
| Test to measure expiratory airflow and volume | 16 | $476 | $28 |
2022: 26 services
| Return visit (30+ min) | 224 | $52,205 | $117 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 20 | $46,580 | $81 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 67 | $29,895 | $59 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 77 | $28,188 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $26,786 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 124 | $22,977 | $175 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 61 | $22,656 | $38 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 67 | $21,960 | $48 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 18 | $20,581 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $18,924 | $64 |
| Long return visit (40+ min) | 64 | $13,310 | $166 |
| New patient visit (45+ min) | 56 | $8,139 | $145 |
| Short return visit (20+ min) | 49 | $5,063 | $82 |
| Sleep study including heart rate, breathing, airflow, and effort | 42 | $4,071 | $87 |
| New patient visit (60+ min) | 24 | $3,988 | $166 |
| Hospital discharge day management, more than 30 minutes | 38 | $3,676 | $97 |
| Test to examine how well the lungs exchange gases | 49 | $3,097 | $62 |
| Test to determine lung volumes using sensors | 48 | $2,797 | $56 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 13 | $2,566 | $151 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 45 | $1,805 | $40 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $927 | $58 |
| Test to measure largest amount of air breathed in an out | 49 | $786 | $16 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 37 | $678 | $18 |
| Test for exercise-induced lung stress | 13 | $391 | $30 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $265 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 15 | $176 | $10 |
2021: 25 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 16 | $41,297 | $84 |
| Return visit (30+ min) | 171 | $35,145 | $117 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 152 | $34,125 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 132 | $20,710 | $65 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 86 | $19,999 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 95 | $18,610 | $182 |
| Long return visit (40+ min) | 80 | $16,924 | $168 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 16 | $16,547 | $121 |
| Short return visit (20+ min) | 103 | $13,320 | $86 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 38 | $8,284 | $70 |
| New patient visit (60+ min) | 41 | $7,480 | $182 |
| Hospital discharge day management, more than 30 minutes | 69 | $6,970 | $98 |
| New patient visit (45+ min) | 43 | $6,259 | $146 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 33 | $5,493 | $50 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 29 | $5,304 | $40 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $5,077 | $124 |
| Test to examine how well the lungs exchange gases | 61 | $4,035 | $62 |
| Sleep study including heart rate, breathing, airflow, and effort | 39 | $3,914 | $98 |
| Test to determine lung volumes using sensors | 61 | $3,683 | $57 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 61 | $3,161 | $49 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 14 | $2,468 | $154 |
| Test to measure largest amount of air breathed in an out | 57 | $1,148 | $19 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 36 | $755 | $21 |
| Hospital discharge day management, 30 minutes or less | 11 | $739 | $67 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $285 | $24 |
2020: 22 services
| Critical care, first 30-74 minutes | 96 | $43,613 | $214 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 14 | $37,056 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 102 | $23,535 | $66 |
| Return visit (30+ min) | 150 | $20,744 | $96 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 13 | $12,824 | $123 |
| Long return visit (40+ min) | 75 | $12,643 | $130 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 57 | $10,619 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $10,313 | $95 |
| Short return visit (20+ min) | 99 | $9,219 | $65 |
| New patient visit (60+ min) | 42 | $7,961 | $190 |
| New patient visit (45+ min) | 53 | $7,477 | $141 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 78 | $6,520 | $53 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $6,209 | $119 |
| Sleep study including heart rate, breathing, airflow, and effort | 32 | $4,120 | $118 |
| Sleep study in sleep lab (6 years or older) | 25 | $2,244 | $90 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 20 | $2,079 | $99 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 11 | $1,914 | $147 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,727 | $102 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $740 | $39 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 28 | $328 | $12 |
| Test to determine lung volumes using sensors | 28 | $309 | $11 |
| Test to examine how well the lungs exchange gases | 23 | $186 | $8 |
2019: 25 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $34,481 | $92 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 18 | $29,230 | $82 |
| Critical care, first 30-74 minutes | 62 | $28,501 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 119 | $21,607 | $65 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $20,710 | $120 |
| Return visit (30+ min) | 117 | $19,451 | $97 |
| Sleep study in sleep lab (6 years or older) | 25 | $16,636 | $640 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $15,041 | $181 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 18 | $12,078 | $671 |
| Long return visit (40+ min) | 52 | $8,983 | $134 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 19 | $8,640 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $7,696 | $122 |
| New patient visit (45+ min) | 50 | $7,433 | $149 |
| New patient visit (60+ min) | 37 | $6,599 | $178 |
| Short return visit (20+ min) | 59 | $5,241 | $67 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 16 | $3,481 | $151 |
| Sleep study including heart rate, breathing, airflow, and effort | 17 | $2,536 | $141 |
| Sleep study in sleep lab (6 years or older) | 16 | $1,759 | $110 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 11 | $1,256 | $114 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 15 | $1,230 | $82 |
| Test for exercise-induced lung stress | 14 | $581 | $32 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 31 | $367 | $12 |
| Test to determine lung volumes using sensors | 31 | $345 | $11 |
| Test to examine how well the lungs exchange gases | 28 | $230 | $8 |
| Evaluation of use of breathing device | 13 | $227 | $17 |
2018: 23 services
| Critical care, first 30-74 minutes | 172 | $81,241 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 120 | $24,549 | $93 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 19 | $20,614 | $62 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 19 | $20,481 | $120 |
| Return visit (30+ min) | 119 | $19,181 | $93 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 19 | $15,679 | $82 |
| Sleep study in sleep lab (6 years or older) | 24 | $15,439 | $643 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 101 | $14,251 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,416 | $180 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 16 | $10,898 | $681 |
| Collection and interpretation of physical parameters stored in computers and/or transmitted by the patient and/or caregiver to qualified health care professional, requiring 30 minutes or more, per 30 days | 69 | $6,297 | $50 |
| Short return visit (20+ min) | 62 | $6,123 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,771 | $120 |
| Long return visit (40+ min) | 30 | $5,595 | $136 |
| New patient visit (45+ min) | 34 | $4,935 | $145 |
| Hospital discharge day management, more than 30 minutes | 38 | $3,851 | $99 |
| Sleep study including heart rate, breathing, airflow, and effort | 22 | $3,808 | $166 |
| New patient visit (60+ min) | 19 | $3,493 | $184 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 16 | $2,892 | $145 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 12 | $1,363 | $105 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $271 | $11 |
| Test to determine lung volumes using sensors | 24 | $256 | $11 |
| Test to examine how well the lungs exchange gases | 22 | $172 | $8 |
2017: 23 services
| Critical care, first 30-74 minutes | 225 | $141,592 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 346 | $58,898 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 239 | $52,873 | $88 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 288 | $35,011 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 131 | $22,888 | $166 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 22 | $19,566 | $59 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 23 | $19,521 | $116 |
| Return visit (30+ min) | 113 | $18,797 | $91 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 22 | $15,850 | $79 |
| Hospital discharge day management, 30 minutes or less | 235 | $15,081 | $58 |
| Sleep study in sleep lab (6 years or older) | 21 | $13,437 | $611 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 17 | $12,727 | $636 |
| Hospital discharge day management, more than 30 minutes | 75 | $6,710 | $88 |
| New patient visit (45+ min) | 41 | $5,718 | $139 |
| Short return visit (20+ min) | 65 | $5,188 | $61 |
| New patient visit (60+ min) | 24 | $4,385 | $183 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 20 | $4,210 | $145 |
| Long return visit (40+ min) | 26 | $3,770 | $130 |
| Diagnostic exam of lung airway using an endoscope | 11 | $2,162 | $114 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 17 | $1,831 | $102 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $283 | $11 |
| Test to determine lung volumes using sensors | 26 | $277 | $11 |
| Test to examine how well the lungs exchange gases | 26 | $205 | $8 |
2016: 24 services
| Critical care, first 30-74 minutes | 160 | $92,618 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 204 | $37,103 | $59 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 35 | $22,799 | $386 |
| Return visit (30+ min) | 123 | $20,455 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 152 | $19,316 | $111 |
| Sleep study in sleep lab (6 years or older) | 31 | $19,255 | $378 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $16,235 | $89 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 20 | $11,712 | $118 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 15 | $11,533 | $61 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 18 | $9,600 | $80 |
| Short return visit (20+ min) | 93 | $8,343 | $61 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $8,161 | $110 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 17 | $7,779 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,801 | $170 |
| New patient visit (45+ min) | 47 | $6,767 | $144 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 17 | $6,708 | $75 |
| Hospital discharge day management, 30 minutes or less | 101 | $6,655 | $58 |
| Long return visit (40+ min) | 22 | $4,125 | $129 |
| New patient visit (60+ min) | 22 | $4,003 | $182 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 11 | $1,126 | $102 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 30 | $339 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $339 | $19 |
| Test to determine lung volumes using sensors | 30 | $319 | $11 |
| Test to examine how well the lungs exchange gases | 30 | $236 | $8 |
2015: 24 services
| Critical care, first 30-74 minutes | 145 | $82,417 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 113 | $28,881 | $91 |
| Return visit (30+ min) | 134 | $28,573 | $98 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 17 | $25,523 | $82 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 33 | $20,734 | $319 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $16,669 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 108 | $15,486 | $64 |
| Sleep study in sleep lab (6 years or older) | 23 | $14,484 | $315 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 15 | $12,037 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,329 | $176 |
| New patient visit (45+ min) | 63 | $8,854 | $141 |
| Long return visit (40+ min) | 36 | $8,260 | $133 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $6,595 | $120 |
| New patient visit (60+ min) | 32 | $5,869 | $183 |
| Short return visit (20+ min) | 47 | $4,797 | $67 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 19 | $2,034 | $107 |
| Diagnostic exam of lung airway using an endoscope | 11 | $1,616 | $124 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 11 | $1,453 | $112 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 13 | $1,233 | $95 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $541 | $19 |
| Evaluation of use of breathing device | 14 | $306 | $18 |
| Test to determine lung volumes using sensors | 19 | $208 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $174 | $12 |
| Test to examine how well the lungs exchange gases | 19 | $153 | $8 |
2014: 25 services
| Critical care, first 30-74 minutes | 157 | $114,936 | $195 |
| Sleep study in sleep lab (6 years or older) | 59 | $36,238 | $307 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $29,020 | $92 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 42 | $27,438 | $323 |
| Return visit (30+ min) | 111 | $24,507 | $97 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 16 | $19,635 | $83 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $18,489 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 106 | $16,333 | $64 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 16 | $13,955 | $63 |
| New patient visit (45+ min) | 78 | $11,654 | $149 |
| Long return visit (40+ min) | 39 | $8,519 | $133 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 44 | $7,914 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 59 | $7,911 | $122 |
| Short return visit (20+ min) | 69 | $6,769 | $64 |
| New patient visit (60+ min) | 30 | $5,652 | $188 |
| Biopsy of lobe of lung using an endoscope, 1 lobe | 14 | $2,183 | $156 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 26 | $2,158 | $83 |
| Change of breathing tube in windpipe | 16 | $1,960 | $32 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 18 | $1,711 | $95 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 14 | $1,492 | $107 |
| Evaluation of use of breathing device | 32 | $643 | $18 |
| Exam of lung airways using an endoscope | 16 | $412 | $26 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 33 | $387 | $12 |
| Test to determine lung volumes using sensors | 35 | $387 | $11 |
| Test to examine how well the lungs exchange gases | 31 | $253 | $8 |
2013: 27 services
| Critical care, first 30-74 minutes | 174 | $128,148 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 150 | $32,165 | $90 |
| Sleep study in sleep lab (6 years or older) | 35 | $23,772 | $326 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 33 | $23,482 | $345 |
| Return visit (30+ min) | 106 | $20,490 | $98 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 24 | $19,371 | $81 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 24 | $15,817 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $11,529 | $62 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 22 | $9,796 | $61 |
| Long return visit (40+ min) | 43 | $9,011 | $133 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 63 | $8,472 | $119 |
| Short return visit (20+ min) | 68 | $7,642 | $65 |
| New patient visit (45+ min) | 46 | $6,622 | $144 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,493 | $175 |
| New patient visit (60+ min) | 29 | $5,405 | $186 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 27 | $2,911 | $104 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 23 | $2,693 | $104 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 15 | $2,494 | $147 |
| Diagnostic exam of lung airway using an endoscope | 14 | $1,952 | $130 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 14 | $1,581 | $93 |
| Aspiration of fluid from chest cavity | 19 | $1,425 | $75 |
| Sleep study including heart rate, breathing, airflow, and effort | 17 | $1,054 | $59 |
| Test to determine lung volumes using sensors | 39 | $452 | $12 |
| Change of breathing tube in windpipe | 11 | $446 | $28 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 38 | $438 | $12 |
| Test to examine how well the lungs exchange gases | 35 | $295 | $8 |
| Exam of lung airways using an endoscope | 15 | $280 | $18 |
Medicaid work
$5,955 in 2024
Medicaid paid $5,955 for 658 billed services this clinician did in 2024, up to 24 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 231 | $2,705 |
| Return visit (30+ min) | 102 | $1,380 |
| Collection and interpretation of physiologic data (eg, ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time, each 30 days | 152 | $837 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 120 | $590 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 14 | $292 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $103 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 12 | $46 |
| 2024 | 658 | 7 | 24 | $5,955 |
| 2023 | 1,544 | 10 | 24 | $19,975 |
| 2022 | 1,140 | 6 | 21 | $16,865 |
| 2021 | 1,088 | 6 | 21 | $22,713 |
| 2020 | 719 | 4 | 20 | $16,687 |
| 2019 | 75 | 3 | 21 | $1,674 |
| 2018 | 22 | 1 | 12 | $566 |
See the largest Medicaid services in earlier years
2023
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 723 | $9,705 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 233 | $3,874 |
| Return visit (30+ min) | 160 | $3,206 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 169 | $1,281 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 84 | $414 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 42 | $399 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 41 | $396 |
| 1ST HOSP IP/OBS HIGH 75 | 43 | $248 |
| Collection and interpretation of physiologic data (eg, ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time, each 30 days | 37 | $237 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 12 | $215 |
2022
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 668 | $9,216 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 150 | $3,517 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 195 | $3,392 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 62 | $598 |
| Return visit (30+ min) | 53 | $114 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 12 | $27 |
2021
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 668 | $14,418 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 173 | $4,171 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 82 | $1,963 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 141 | $1,459 |
| New patient visit (30+ min) | 12 | $560 |
| Return visit (30+ min) | 12 | $142 |
2020
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 424 | $8,082 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 138 | $5,636 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 100 | $2,256 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 57 | $714 |
2019
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 39 | $718 |
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 23 | $517 |
| SBSQ NURSING FACILITY CARE HIGH MDM 45 MINUTES | 13 | $439 |
2018
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 22 | $566 |
Drugs they prescribed that Part D paid
$416,340
Pharmacies billed $416,340 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,593 generic and fewer than 11 brand-name prescriptions · $416,340 in drug cost · 137 antibiotic prescriptions to 49 people · 20 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 168 | $135,556 | $807 |
| Breo Ellipta | 65 | $26,832 | $413 |
| Spiriva Handihaler | 24 | $18,629 | $776 |
| Lacosamide | 11 | $11,057 | $1,005 |
| Incruse Ellipta | 15 | $9,219 | $615 |
See all 60 drugs
| Trelegy Ellipta | 168 | $135,556 | $807 |
| Breo Ellipta | 65 | $26,832 | $413 |
| Spiriva Handihaler | 24 | $18,629 | $776 |
| Lacosamide | 11 | $11,057 | $1,005 |
| Incruse Ellipta | 15 | $9,219 | $615 |
| Spiriva Respimat | 15 | $8,654 | $577 |
| Eliquis | 27 | $7,703 | $285 |
| Pantoprazole | 23 | $5,945 | $258 |
| Semglee (Yfgn) | 17 | $5,083 | $299 |
| Rifabutin | 14 | $5,078 | $363 |
| Potassium Chloride | 30 | $4,652 | $155 |
| Renacidin | 18 | $3,080 | $171 |
| Basaglar Kwikpen U-100 | 26 | $2,759 | $106 |
| Ipratropium-Albuterol | 77 | $2,667 | $35 |
| Symbicort | 11 | $2,615 | $238 |
| Piperacillin-Tazobactam | 17 | $2,547 | $150 |
| Albuterol Sulfate Hfa | 85 | $2,316 | $27 |
| Gabapentin | 34 | $2,218 | $65 |
| Baclofen | 60 | $2,169 | $36 |
| Breyna | 15 | $2,162 | $144 |
| Levetiracetam | 24 | $1,919 | $80 |
| Famotidine | 104 | $1,903 | $18 |
| Budesonide | 11 | $1,561 | $142 |
| Amlodipine Besylate | 91 | $1,273 | $14 |
| Lantus | 17 | $1,222 | $72 |
| Atorvastatin | 44 | $1,136 | $26 |
| Admelog | 15 | $1,116 | $74 |
| Azithromycin | 56 | $990 | $18 |
| Carbidopa-Levodopa | 16 | $987 | $62 |
| Metformin | 75 | $906 | $12 |
| Doxazosin Mesylate | 39 | $892 | $23 |
| Fenofibrate | 21 | $804 | $38 |
| Topiramate | 12 | $800 | $67 |
| Metoclopramide | 22 | $710 | $32 |
| Quetiapine | 19 | $697 | $37 |
| Propranolol | 16 | $696 | $43 |
| Losartan | 35 | $673 | $19 |
| Ethambutol | 13 | $666 | $51 |
| Metoprolol | 44 | $620 | $14 |
| Sodium Chloride | 33 | $603 | $18 |
| Fluticasone Propionate | 51 | $542 | $11 |
| Prednisone | 45 | $525 | $12 |
| Rifampin | 11 | $521 | $47 |
| Furosemide | 62 | $516 | $8 |
| Ondansetron | 19 | $485 | $26 |
| Hydralazine | 19 | $445 | $23 |
| Diltiazem | 14 | $424 | $30 |
| Roflumilast | 11 | $414 | $38 |
| Nystatin | 15 | $384 | $26 |
| Glipizide | 26 | $367 | $14 |
| Rosuvastatin | 14 | $332 | $24 |
| Fenofibrate | 12 | $317 | $26 |
| Levothyroxine | 28 | $300 | $11 |
| Montelukast | 37 | $270 | $7 |
| Triamcinolone Acetonide | 20 | $252 | $13 |
| Finasteride | 12 | $204 | $17 |
| Citalopram Hbr | 13 | $202 | $16 |
| Carvedilol | 14 | $186 | $13 |
| Chlorhexidine Gluconate | 14 | $163 | $12 |
| Folic Acid | 11 | $74 | $7 |
Year by year
| 2024 | 2,308 | 193 | None | None | $416,340 |
| 2023 | 2,725 | 206 | 1% (22) | 28% | $515,905 |
| 2022 | 3,000 | 223 | 1% (31) | None | $481,578 |
| 2021 | 2,576 | 211 | 1% (31) | None | $382,955 |
| 2020 | 2,506 | 157 | 1% (36) | None | $308,975 |
| 2019 | 2,422 | 107 | 2% (54) | None | $259,722 |
| 2018 | 2,586 | 119 | 3% (89) | None | $327,175 |
| 2017 | 2,550 | 117 | 5% (137) | None | $454,238 |
| 2016 | 2,805 | 117 | 6% (153) | None | $448,740 |
| 2015 | 2,742 | 104 | 4% (110) | 32% | $347,740 |
| 2014 | 2,602 | 105 | 5% (134) | 36% | $352,715 |
| 2013 | 2,059 | 97 | 5% (109) | 36% | $237,933 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 74 drugs
| Trelegy Ellipta | 178 | $140,652 | $790 |
| Xolair | 13 | $100,573 | $7,736 |
| Breo Ellipta | 38 | $17,097 | $450 |
| Symbicort | 34 | $16,505 | $485 |
| Spiriva Handihaler | 21 | $15,059 | $717 |
| Incruse Ellipta | 20 | $11,987 | $599 |
| Spiriva Respimat | 20 | $11,317 | $566 |
| Anoro Ellipta | 11 | $8,452 | $768 |
| Wixela Inhub | 19 | $8,356 | $440 |
| Pantoprazole | 41 | $8,066 | $197 |
| Budesonide | 38 | $7,717 | $203 |
| Eliquis | 26 | $7,643 | $294 |
| Potassium Chloride | 48 | $7,122 | $148 |
| Novolog | 21 | $6,620 | $315 |
| Lantus | 12 | $6,556 | $546 |
| Renacidin | 32 | $6,510 | $203 |
| Ipratropium-Albuterol | 173 | $5,102 | $29 |
| Baclofen | 73 | $4,015 | $55 |
| Albuterol Sulfate Hfa | 83 | $3,254 | $39 |
| Semglee (Yfgn) | 12 | $2,704 | $225 |
| Piperacillin-Tazobactam | 11 | $2,414 | $219 |
| Insulin Aspart | 13 | $2,065 | $159 |
| Famotidine | 119 | $2,008 | $17 |
| Amiodarone | 11 | $2,002 | $182 |
| Levetiracetam | 33 | $1,767 | $54 |
| Rosuvastatin | 14 | $1,615 | $115 |
| Gabapentin | 40 | $1,520 | $38 |
| Metoclopramide | 44 | $1,343 | $31 |
| Carbidopa-Levodopa | 15 | $1,211 | $81 |
| Glycopyrrolate | 14 | $1,180 | $84 |
| Metformin | 81 | $1,179 | $15 |
| Azithromycin | 55 | $1,168 | $21 |
| Prednisone | 96 | $1,103 | $11 |
| Basaglar Kwikpen U-100 | 15 | $1,101 | $73 |
| Autoshield Duo Pen Needle | 12 | $1,088 | $91 |
| Clonidine | 12 | $1,018 | $85 |
| Fluticasone Propionate | 40 | $997 | $25 |
| Amlodipine Besylate | 74 | $900 | $12 |
| Diltiazem | 21 | $892 | $42 |
| Nystop | 18 | $885 | $49 |
| Lactulose | 26 | $729 | $28 |
| Pravastatin | 12 | $722 | $60 |
| Sodium Chloride | 24 | $700 | $29 |
| Furosemide | 62 | $634 | $10 |
| Latanoprost | 23 | $617 | $27 |
| Topiramate | 12 | $584 | $49 |
| Nystatin | 16 | $545 | $34 |
| Quetiapine | 19 | $542 | $29 |
| Montelukast | 34 | $525 | $15 |
| Lisinopril | 38 | $504 | $13 |
| Triamcinolone Acetonide | 26 | $474 | $18 |
| Doxazosin Mesylate | 18 | $455 | $25 |
| Dorzolamide | 11 | $428 | $39 |
| Metoprolol | 37 | $412 | $11 |
| Finasteride | 22 | $404 | $18 |
| Carvedilol | 26 | $376 | $14 |
| Atorvastatin | 20 | $354 | $18 |
| Rifampin | 11 | $343 | $31 |
| Mirtazapine | 16 | $332 | $21 |
| Ondansetron | 14 | $319 | $23 |
| Ceftriaxone | 11 | $304 | $28 |
| Glipizide | 25 | $277 | $11 |
| Amitriptyline | 12 | $277 | $23 |
| Losartan | 27 | $273 | $10 |
| Fenofibrate | 12 | $267 | $22 |
| Brimonidine | 16 | $239 | $15 |
| Levothyroxine | 18 | $204 | $11 |
| Sulfamethoxazole-Trimethoprim | 12 | $187 | $16 |
| Hydralazine | 11 | $171 | $16 |
| Chlorhexidine Gluconate | 11 | $130 | $12 |
| Cephalexin | 12 | $130 | $11 |
| Citalopram Hbr | 12 | $92 | $8 |
| Folic Acid | 13 | $87 | $7 |
| Levofloxacin | 11 | $83 | $8 |
2022: 79 drugs
| Trelegy Ellipta | 104 | $84,712 | $815 |
| Incruse Ellipta | 62 | $31,471 | $508 |
| Advair Diskus | 44 | $23,081 | $525 |
| Symbicort | 28 | $19,608 | $700 |
| Spiriva Handihaler | 25 | $19,147 | $766 |
| Breo Ellipta | 39 | $17,475 | $448 |
| Eliquis | 40 | $10,603 | $265 |
| Vimpat | 15 | $7,920 | $528 |
| Potassium Chloride | 54 | $7,767 | $144 |
| Wixela Inhub | 15 | $7,635 | $509 |
| Restasis | 13 | $7,243 | $557 |
| Anoro Ellipta | 15 | $7,233 | $482 |
| Lantus | 21 | $6,574 | $313 |
| Budesonide | 36 | $6,386 | $177 |
| Novolog | 20 | $6,301 | $315 |
| Spiriva Respimat | 12 | $6,248 | $521 |
| Pantoprazole | 29 | $5,790 | $200 |
| Baclofen | 72 | $5,604 | $78 |
| Albuterol Sulfate Hfa | 122 | $5,289 | $43 |
| Flovent Diskus | 16 | $4,510 | $282 |
| Ipratropium-Albuterol | 131 | $4,158 | $32 |
| Pulmicort Flexhaler | 13 | $3,827 | $294 |
| Famotidine | 133 | $3,679 | $28 |
| Arnuity Ellipta | 12 | $3,221 | $268 |
| Budesonide-Formoterol | 13 | $2,674 | $206 |
| Gabapentin | 49 | $2,371 | $48 |
| Amiodarone | 13 | $2,306 | $177 |
| Rosuvastatin | 13 | $2,017 | $155 |
| Levetiracetam | 54 | $1,917 | $36 |
| Clonidine | 12 | $1,825 | $152 |
| Novolin R | 11 | $1,651 | $150 |
| Ventolin Hfa | 19 | $1,616 | $85 |
| Azithromycin | 72 | $1,407 | $20 |
| Metoclopramide | 54 | $1,350 | $25 |
| Pravastatin | 21 | $1,195 | $57 |
| Ceftriaxone | 13 | $1,194 | $92 |
| Metformin | 82 | $1,069 | $13 |
| Prednisone | 99 | $885 | $9 |
| Levothyroxine | 71 | $865 | $12 |
| Carbidopa-Levodopa | 13 | $837 | $64 |
| Amlodipine Besylate | 68 | $800 | $12 |
| Topiramate | 12 | $759 | $63 |
| Montelukast | 46 | $711 | $15 |
| Fluticasone Propionate | 43 | $710 | $17 |
| Quetiapine | 25 | $705 | $28 |
| Lisinopril | 57 | $694 | $12 |
| Ethambutol | 16 | $687 | $43 |
| Ondansetron | 16 | $682 | $43 |
| Furosemide | 62 | $663 | $11 |
| Nystop | 17 | $633 | $37 |
| Levalbuterol | 11 | $616 | $56 |
| Lactulose | 34 | $613 | $18 |
| Diltiazem | 23 | $588 | $26 |
| Atorvastatin | 30 | $581 | $19 |
| Nystatin | 15 | $521 | $35 |
| Finasteride | 26 | $515 | $20 |
| Metoprolol | 59 | $510 | $9 |
| Latanoprost | 20 | $467 | $23 |
| Carvedilol | 40 | $417 | $10 |
| Amitriptyline | 22 | $388 | $18 |
| Zolpidem | 35 | $340 | $10 |
| Rifampin | 12 | $301 | $25 |
| Omeprazole | 18 | $290 | $16 |
| Glipizide | 25 | $288 | $12 |
| Nitrofurantoin | 24 | $278 | $12 |
| Fenofibrate | 12 | $268 | $22 |
| Doxazosin Mesylate | 11 | $268 | $24 |
| Brimonidine | 15 | $262 | $17 |
| Clopidogrel | 18 | $246 | $14 |
| Mirtazapine | 14 | $232 | $17 |
| Trazodone | 16 | $220 | $14 |
| Chlorhexidine Gluconate | 14 | $169 | $12 |
| Levofloxacin | 17 | $160 | $9 |
| Citalopram Hbr | 16 | $160 | $10 |
| Tramadol | 14 | $128 | $9 |
| Cephalexin | 11 | $124 | $11 |
| Donepezil | 11 | $114 | $10 |
| Sertraline | 11 | $92 | $8 |
| Folic Acid | 11 | $70 | $6 |
2021: 71 drugs
| Trelegy Ellipta | 77 | $62,871 | $817 |
| Incruse Ellipta | 58 | $32,587 | $562 |
| Breo Ellipta | 62 | $25,253 | $407 |
| Symbicort | 35 | $20,737 | $592 |
| Advair Diskus | 21 | $16,049 | $764 |
| Spiriva Respimat | 30 | $15,764 | $525 |
| Anoro Ellipta | 19 | $12,830 | $675 |
| Spiriva | 18 | $12,364 | $687 |
| Wixela Inhub | 28 | $9,130 | $326 |
| Eliquis | 26 | $7,550 | $290 |
| Flovent Hfa | 17 | $7,269 | $428 |
| Budesonide | 19 | $6,750 | $355 |
| Restasis | 19 | $6,297 | $331 |
| Novolog | 19 | $5,992 | $315 |
| Baclofen | 90 | $5,567 | $62 |
| Lantus | 16 | $5,032 | $314 |
| Potassium Chloride | 44 | $4,717 | $107 |
| Ipratropium-Albuterol | 115 | $4,329 | $38 |
| Levemir | 12 | $3,945 | $329 |
| Gabapentin | 53 | $3,302 | $62 |
| Albuterol Sulfate Hfa | 57 | $3,039 | $53 |
| Pantoprazole | 17 | $2,911 | $171 |
| Piperacillin-Tazobactam | 17 | $2,523 | $148 |
| Ventolin Hfa | 27 | $2,020 | $75 |
| Clonidine | 13 | $1,985 | $153 |
| Famotidine | 113 | $1,945 | $17 |
| Renacidin | 17 | $1,861 | $109 |
| Novolin R | 11 | $1,645 | $150 |
| Levetiracetam | 42 | $1,417 | $34 |
| Pravastatin | 26 | $1,256 | $48 |
| Prednisone | 99 | $1,171 | $12 |
| Nystop | 31 | $1,128 | $36 |
| Azithromycin | 56 | $1,107 | $20 |
| Amlodipine Besylate | 57 | $1,060 | $19 |
| Levothyroxine | 79 | $1,001 | $13 |
| Fluticasone Propionate | 62 | $959 | $15 |
| Metformin | 67 | $925 | $14 |
| Tamsulosin | 19 | $895 | $47 |
| Metoclopramide | 23 | $893 | $39 |
| Finasteride | 39 | $870 | $22 |
| Carbidopa-Levodopa | 12 | $793 | $66 |
| Oxybutynin Chloride | 21 | $755 | $36 |
| Montelukast | 45 | $591 | $13 |
| Atorvastatin | 29 | $580 | $20 |
| Furosemide | 51 | $525 | $10 |
| Quetiapine | 17 | $515 | $30 |
| Lisinopril | 40 | $506 | $13 |
| Fenofibrate | 12 | $506 | $42 |
| Triamcinolone Acetonide | 24 | $501 | $21 |
| Omeprazole | 26 | $495 | $19 |
| Fenofibrate | 22 | $479 | $22 |
| Metoprolol | 34 | $467 | $14 |
| Diclofenac | 14 | $460 | $33 |
| Diltiazem | 14 | $451 | $32 |
| Ondansetron | 11 | $414 | $38 |
| Topiramate | 12 | $411 | $34 |
| Levofloxacin | 24 | $341 | $14 |
| Glipizide | 24 | $334 | $14 |
| Rosuvastatin | 13 | $330 | $25 |
| Ceftriaxone | 12 | $297 | $25 |
| Carvedilol | 19 | $295 | $16 |
| Hydrocodone-Acetaminophen | 18 | $294 | $16 |
| Ketoconazole | 14 | $280 | $20 |
| Latanoprost | 13 | $260 | $20 |
| Simvastatin | 15 | $254 | $17 |
| Zolpidem | 15 | $223 | $15 |
| Amitriptyline | 11 | $185 | $17 |
| Clopidogrel | 14 | $160 | $11 |
| Sertraline | 13 | $119 | $9 |
| Tramadol | 12 | $118 | $10 |
| Folic Acid | 13 | $85 | $7 |
2020: 72 drugs
| Trelegy Ellipta | 35 | $29,956 | $856 |
| Breo Ellipta | 57 | $23,844 | $418 |
| Incruse Ellipta | 45 | $23,176 | $515 |
| Advair Diskus | 19 | $16,136 | $849 |
| Spiriva | 15 | $13,501 | $900 |
| Anoro Ellipta | 21 | $13,105 | $624 |
| Eliquis | 50 | $12,107 | $242 |
| Novolog | 38 | $11,977 | $315 |
| Flovent Hfa | 20 | $10,414 | $521 |
| Potassium Chloride | 49 | $9,862 | $201 |
| Spiriva Respimat | 17 | $9,616 | $566 |
| Protonix | 13 | $6,726 | $517 |
| Budesonide | 17 | $6,487 | $382 |
| Wixela Inhub | 19 | $6,132 | $323 |
| Restasis | 19 | $6,020 | $317 |
| Ipratropium-Albuterol | 116 | $4,425 | $38 |
| Carafate | 12 | $4,326 | $360 |
| Lantus | 13 | $4,088 | $314 |
| Levemir | 11 | $3,626 | $330 |
| Albuterol Sulfate Hfa | 58 | $3,474 | $60 |
| Baclofen | 66 | $3,199 | $48 |
| Gabapentin | 40 | $2,772 | $69 |
| Fluticasone-Salmeterol | 12 | $2,671 | $223 |
| Famotidine | 120 | $2,326 | $19 |
| Levetiracetam | 30 | $2,036 | $68 |
| Meropenem | 14 | $1,954 | $140 |
| Esomeprazole Magnesium | 14 | $1,789 | $128 |
| Ventolin Hfa | 24 | $1,615 | $67 |
| Clonidine | 12 | $1,598 | $133 |
| Basaglar Kwikpen U-100 | 20 | $1,485 | $74 |
| Piperacillin-Tazobactam | 16 | $1,445 | $90 |
| Metoclopramide | 34 | $1,324 | $39 |
| Pravastatin | 40 | $1,313 | $33 |
| Valproic Acid | 15 | $1,190 | $79 |
| Ondansetron | 24 | $1,167 | $49 |
| Pregabalin | 14 | $1,123 | $80 |
| Azithromycin | 57 | $1,027 | $18 |
| Prednisone | 96 | $982 | $10 |
| Humulin R | 12 | $946 | $79 |
| Metformin | 77 | $934 | $12 |
| Furosemide | 66 | $848 | $13 |
| Finasteride | 45 | $847 | $19 |
| Fluticasone Propionate | 43 | $839 | $20 |
| Tamsulosin | 24 | $747 | $31 |
| Amlodipine Besylate | 65 | $738 | $11 |
| Mycophenolate Mofetil | 11 | $613 | $56 |
| Fenofibrate | 11 | $590 | $54 |
| Levothyroxine | 50 | $576 | $12 |
| Atorvastatin | 36 | $524 | $15 |
| Diltiazem | 17 | $512 | $30 |
| Fenofibrate | 24 | $492 | $21 |
| Metoprolol | 42 | $467 | $11 |
| Glipizide | 33 | $414 | $13 |
| Levofloxacin | 18 | $356 | $20 |
| Lactulose | 14 | $344 | $25 |
| Topiramate | 14 | $334 | $24 |
| Omeprazole | 18 | $323 | $18 |
| Montelukast | 18 | $319 | $18 |
| Lisinopril | 38 | $311 | $8 |
| Rosuvastatin | 13 | $289 | $22 |
| Paroxetine | 12 | $270 | $23 |
| Lorazepam | 19 | $235 | $12 |
| Warfarin | 30 | $200 | $7 |
| Zolpidem | 18 | $186 | $10 |
| Latanoprost | 11 | $183 | $17 |
| Cyclobenzaprine | 14 | $158 | $11 |
| Hydrocodone-Acetaminophen | 16 | $150 | $9 |
| Carvedilol | 18 | $132 | $7 |
| Ropinirole | 13 | $105 | $8 |
| Tramadol | 12 | $94 | $8 |
| Sulfamethoxazole-Trimethoprim | 19 | $87 | $5 |
| Donepezil | 11 | $81 | $7 |
2019: 61 drugs
| Trelegy Ellipta | 35 | $24,563 | $702 |
| Breo Ellipta | 45 | $19,167 | $426 |
| Erythromycin Ethylsuccinate | 19 | $18,922 | $996 |
| Incruse Ellipta | 22 | $12,830 | $583 |
| Budesonide | 34 | $11,042 | $325 |
| Anoro Ellipta | 26 | $10,925 | $420 |
| Potassium Chloride | 39 | $9,485 | $243 |
| Flovent Hfa | 21 | $7,289 | $347 |
| Restasis | 23 | $6,949 | $302 |
| Spiriva Respimat | 15 | $6,260 | $417 |
| Novolog | 19 | $5,918 | $311 |
| Advair Diskus | 15 | $5,460 | $364 |
| Lyrica | 32 | $5,406 | $169 |
| Eliquis | 21 | $4,730 | $225 |
| Paxil | 13 | $4,624 | $356 |
| Famotidine | 117 | $4,354 | $37 |
| Ipratropium-Albuterol | 127 | $4,341 | $34 |
| Novolin R | 27 | $4,021 | $149 |
| Enoxaparin | 13 | $3,234 | $249 |
| Acetylcysteine | 31 | $3,224 | $104 |
| Gabapentin | 40 | $2,682 | $67 |
| Symbicort | 11 | $2,540 | $231 |
| Baclofen | 61 | $1,963 | $32 |
| Levetiracetam | 21 | $1,740 | $83 |
| Pravastatin | 61 | $1,719 | $28 |
| Prednisone | 99 | $1,660 | $17 |
| Permethrin | 20 | $1,605 | $80 |
| Azithromycin | 61 | $1,475 | $24 |
| Humulin R | 23 | $1,293 | $56 |
| Nystop | 34 | $1,273 | $37 |
| Vancomycin | 17 | $1,046 | $62 |
| Metformin | 89 | $813 | $9 |
| Venlafaxine | 19 | $760 | $40 |
| Ventolin Hfa | 13 | $690 | $53 |
| Pregabalin | 16 | $685 | $43 |
| Amlodipine Besylate | 46 | $634 | $14 |
| Morphine Sulfate | 25 | $612 | $24 |
| Ranitidine | 37 | $603 | $16 |
| Glipizide | 56 | $563 | $10 |
| Levothyroxine | 42 | $557 | $13 |
| Finasteride | 32 | $541 | $17 |
| Furosemide | 35 | $539 | $15 |
| Fenofibrate | 25 | $492 | $20 |
| Metoclopramide | 27 | $489 | $18 |
| Atorvastatin | 34 | $484 | $14 |
| Diltiazem | 15 | $476 | $32 |
| Metoprolol | 48 | $454 | $9 |
| Lactulose | 23 | $446 | $19 |
| Lisinopril | 40 | $405 | $10 |
| Sucralfate | 14 | $384 | $27 |
| Topiramate | 13 | $311 | $24 |
| Ondansetron | 13 | $301 | $23 |
| Warfarin | 52 | $286 | $5 |
| Terazosin | 18 | $269 | $15 |
| Montelukast | 17 | $263 | $15 |
| Rosuvastatin | 12 | $251 | $21 |
| Latanoprost | 11 | $225 | $20 |
| Paroxetine | 13 | $225 | $17 |
| Fluticasone Propionate | 11 | $205 | $19 |
| Tramadol | 17 | $196 | $12 |
| Zolpidem | 11 | $189 | $17 |
2018: 69 drugs
| Incruse Ellipta | 51 | $22,030 | $432 |
| Erythromycin Ethylsuccinate | 31 | $15,273 | $493 |
| Breo Ellipta | 31 | $15,087 | $487 |
| Anoro Ellipta | 34 | $14,473 | $426 |
| Advair Diskus | 27 | $11,217 | $415 |
| Trelegy Ellipta | 19 | $10,977 | $578 |
| Spiriva | 17 | $10,573 | $622 |
| Budesonide | 34 | $10,247 | $301 |
| Lyrica | 46 | $8,707 | $189 |
| Novolin R | 48 | $7,284 | $152 |
| Lantus | 23 | $6,563 | $285 |
| Flovent Hfa | 17 | $6,449 | $379 |
| Januvia | 26 | $5,711 | $220 |
| Famotidine | 104 | $5,101 | $49 |
| Geodon | 12 | $5,084 | $424 |
| Potassium Chloride | 30 | $4,914 | $164 |
| Spiriva Respimat | 12 | $4,906 | $409 |
| Gabapentin | 47 | $4,385 | $93 |
| Ipratropium-Albuterol | 152 | $4,344 | $29 |
| Carafate | 12 | $3,529 | $294 |
| Humulin R | 37 | $3,215 | $87 |
| Zetonna | 12 | $2,892 | $241 |
| Piperacillin-Tazobactam | 12 | $2,284 | $190 |
| Fenofibrate | 14 | $2,190 | $156 |
| Vancomycin | 19 | $2,006 | $106 |
| Pravastatin | 71 | $1,936 | $27 |
| Levetiracetam | 22 | $1,901 | $86 |
| Prednisone | 85 | $1,869 | $22 |
| Proair Hfa | 19 | $1,749 | $92 |
| Vascepa | 12 | $1,737 | $145 |
| Azithromycin | 43 | $1,492 | $35 |
| Baclofen | 68 | $1,456 | $21 |
| Atropine Sulfate | 26 | $1,429 | $55 |
| Ventolin Hfa | 17 | $937 | $55 |
| Morphine Sulfate | 24 | $860 | $36 |
| Metformin | 75 | $853 | $11 |
| Memantine | 11 | $820 | $75 |
| Lorazepam | 24 | $716 | $30 |
| Glipizide | 84 | $711 | $8 |
| Amlodipine Besylate | 46 | $644 | $14 |
| Zolpidem | 32 | $631 | $20 |
| Atorvastatin | 40 | $628 | $16 |
| Methotrexate | 18 | $603 | $34 |
| Levothyroxine | 41 | $594 | $14 |
| Ranitidine | 32 | $591 | $18 |
| Triamcinolone Acetonide | 28 | $583 | $21 |
| Methadone Intensol | 18 | $574 | $32 |
| Sucralfate | 18 | $535 | $30 |
| Venlafaxine | 15 | $507 | $34 |
| Montelukast | 23 | $453 | $20 |
| Finasteride | 25 | $446 | $18 |
| Lisinopril | 47 | $408 | $9 |
| Latanoprost | 17 | $352 | $21 |
| Terazosin | 24 | $352 | $15 |
| Metoclopramide | 17 | $348 | $20 |
| Fluticasone Propionate | 19 | $331 | $17 |
| Metoprolol | 34 | $326 | $10 |
| Topiramate | 12 | $319 | $27 |
| Tramadol | 28 | $310 | $11 |
| Lactulose | 20 | $306 | $15 |
| Quetiapine | 17 | $303 | $18 |
| Tamsulosin | 15 | $268 | $18 |
| Levofloxacin | 18 | $263 | $15 |
| Paroxetine | 13 | $236 | $18 |
| Hydrocodone-Acetaminophen | 15 | $210 | $14 |
| Benztropine Mesylate | 12 | $176 | $15 |
| Cephalexin | 13 | $132 | $10 |
| Furosemide | 11 | $110 | $10 |
| Fluoxetine | 11 | $107 | $10 |
2017: 70 drugs
| Letairis | 17 | $155,864 | $9,168 |
| Relistor | 30 | $33,352 | $1,112 |
| Advair Diskus | 52 | $19,411 | $373 |
| Anoro Ellipta | 52 | $18,273 | $351 |
| Breo Ellipta | 48 | $18,231 | $380 |
| Spiriva | 33 | $18,125 | $549 |
| Incruse Ellipta | 44 | $17,023 | $387 |
| Lyrica | 76 | $16,206 | $213 |
| Spiriva Respimat | 26 | $10,211 | $393 |
| Carafate | 17 | $7,668 | $451 |
| Lantus | 25 | $6,830 | $273 |
| Novolin R | 37 | $5,562 | $150 |
| Flovent Hfa | 17 | $4,636 | $273 |
| Mometasone Furoate | 20 | $3,577 | $179 |
| Famotidine | 108 | $3,448 | $32 |
| Piperacillin-Tazobactam | 15 | $3,401 | $227 |
| Flovent Diskus | 14 | $3,091 | $221 |
| Gabapentin | 48 | $2,665 | $56 |
| Protonix | 12 | $2,507 | $209 |
| Ipratropium-Albuterol | 82 | $2,416 | $29 |
| Potassium Chloride | 14 | $2,388 | $171 |
| Fenofibrate | 24 | $2,315 | $96 |
| Atropine Sulfate | 44 | $2,207 | $50 |
| Pravastatin | 78 | $2,118 | $27 |
| Ursodiol | 15 | $1,903 | $127 |
| Proair Hfa | 25 | $1,894 | $76 |
| Vancomycin | 20 | $1,853 | $93 |
| Heparin | 71 | $1,852 | $26 |
| Fentanyl | 26 | $1,752 | $67 |
| Baclofen | 50 | $1,706 | $34 |
| Humulin R | 12 | $1,581 | $132 |
| Levetiracetam | 34 | $1,543 | $45 |
| Azithromycin | 40 | $1,109 | $28 |
| Memantine | 12 | $872 | $73 |
| Metformin | 70 | $860 | $12 |
| Methadone | 57 | $860 | $15 |
| Tamsulosin | 25 | $843 | $34 |
| Prednisone | 75 | $815 | $11 |
| Carbidopa-Levodopa | 16 | $720 | $45 |
| Metoclopramide | 44 | $668 | $15 |
| Sertraline | 11 | $605 | $55 |
| Hydroxychloroquine Sulfate | 19 | $543 | $29 |
| Venlafaxine | 13 | $543 | $42 |
| Nyamyc | 16 | $498 | $31 |
| Montelukast | 31 | $481 | $16 |
| Ondansetron | 23 | $473 | $21 |
| Glipizide | 52 | $452 | $9 |
| Fluticasone Propionate | 30 | $403 | $13 |
| Lisinopril | 38 | $399 | $11 |
| Levothyroxine | 22 | $374 | $17 |
| Terazosin | 25 | $357 | $14 |
| Latanoprost | 14 | $348 | $25 |
| Finasteride | 18 | $337 | $19 |
| Topiramate | 12 | $327 | $27 |
| Lactulose | 20 | $323 | $16 |
| Gemfibrozil | 12 | $316 | $26 |
| Amlodipine Besylate | 26 | $265 | $10 |
| Simvastatin | 26 | $252 | $10 |
| Tramadol | 31 | $239 | $8 |
| Trazodone | 15 | $222 | $15 |
| Carvedilol | 14 | $195 | $14 |
| Fluoxetine | 13 | $193 | $15 |
| Hydrochlorothiazide | 14 | $192 | $14 |
| Brimonidine | 13 | $185 | $14 |
| Metoprolol | 12 | $176 | $15 |
| Oxycodone | 12 | $165 | $14 |
| Furosemide | 21 | $162 | $8 |
| Ranitidine | 14 | $160 | $11 |
| Clopidogrel | 12 | $158 | $13 |
| Levofloxacin | 16 | $152 | $10 |
2016: 82 drugs
| Letairis | 17 | $151,212 | $8,895 |
| Advair Diskus | 82 | $31,066 | $379 |
| Spiriva | 57 | $25,811 | $453 |
| Relistor | 23 | $24,697 | $1,074 |
| Anoro Ellipta | 38 | $14,396 | $379 |
| Lyrica | 78 | $13,794 | $177 |
| Lantus | 30 | $9,474 | $316 |
| Spiriva Respimat | 27 | $9,041 | $335 |
| Paxil | 12 | $6,901 | $575 |
| Carafate | 12 | $5,942 | $495 |
| Novolin R | 40 | $5,827 | $146 |
| Erythrocin Stearate | 12 | $5,698 | $475 |
| Daliresp | 16 | $4,772 | $298 |
| Vancomycin | 58 | $4,335 | $75 |
| Protonix | 11 | $4,162 | $378 |
| Incruse Ellipta | 13 | $3,657 | $281 |
| Midodrine | 18 | $3,597 | $200 |
| Baclofen | 79 | $3,121 | $40 |
| Famotidine | 92 | $2,994 | $33 |
| Gabapentin | 58 | $2,912 | $50 |
| Flovent Diskus | 11 | $2,820 | $256 |
| Heparin | 67 | $2,654 | $40 |
| Enoxaparin | 16 | $2,637 | $165 |
| Proair Hfa | 28 | $2,514 | $90 |
| Potassium Chloride | 18 | $2,486 | $138 |
| Omega-3 Acid Ethyl Esters | 15 | $1,936 | $129 |
| Ipratropium-Albuterol | 66 | $1,919 | $29 |
| Fentanyl | 21 | $1,906 | $91 |
| Atropine Sulfate | 36 | $1,813 | $50 |
| Fenofibrate | 37 | $1,763 | $48 |
| Pravastatin | 73 | $1,500 | $21 |
| Nexium | 11 | $1,454 | $132 |
| Memantine | 31 | $1,416 | $46 |
| Fenofibrate | 30 | $1,216 | $41 |
| Methadone | 83 | $1,180 | $14 |
| Carbidopa-Levodopa | 32 | $1,091 | $34 |
| Nyamyc | 22 | $1,041 | $47 |
| Prednisone | 91 | $948 | $10 |
| Bethanechol Chloride | 11 | $914 | $83 |
| Hydroxychloroquine Sulfate | 24 | $858 | $36 |
| Montelukast | 45 | $851 | $19 |
| Azithromycin | 43 | $790 | $18 |
| Metformin | 69 | $749 | $11 |
| Ventolin Hfa | 11 | $673 | $61 |
| Levetiracetam | 25 | $660 | $26 |
| Lisinopril | 61 | $595 | $10 |
| Gemfibrozil | 35 | $584 | $17 |
| Tamsulosin | 20 | $560 | $28 |
| Fenofibrate | 13 | $547 | $42 |
| Levothyroxine | 31 | $484 | $16 |
| Atorvastatin | 27 | $464 | $17 |
| Terazosin | 27 | $413 | $15 |
| Ondansetron | 32 | $411 | $13 |
| Lactulose | 17 | $411 | $24 |
| Zaleplon | 12 | $382 | $32 |
| Glipizide | 48 | $370 | $8 |
| Nystatin | 16 | $365 | $23 |
| Metoclopramide | 29 | $364 | $13 |
| Amlodipine Besylate | 40 | $354 | $9 |
| Hydrocodone-Acetaminophen | 16 | $341 | $21 |
| Venlafaxine | 13 | $336 | $26 |
| Carvedilol | 31 | $326 | $11 |
| Levofloxacin | 17 | $264 | $16 |
| Triamcinolone Acetonide | 17 | $256 | $15 |
| Finasteride | 12 | $201 | $17 |
| Topiramate | 11 | $200 | $18 |
| Ranitidine | 13 | $191 | $15 |
| Amiodarone | 11 | $173 | $16 |
| Fluticasone Propionate | 13 | $169 | $13 |
| Tramadol | 20 | $162 | $8 |
| Oxycodone | 12 | $151 | $13 |
| Furosemide | 16 | $128 | $8 |
| Brimonidine | 11 | $126 | $11 |
| Simvastatin | 17 | $126 | $7 |
| Chlorhexidine Gluconate | 14 | $124 | $9 |
| Citalopram Hbr | 12 | $122 | $10 |
| Zolpidem | 15 | $113 | $8 |
| Clonazepam | 15 | $112 | $7 |
| Clopidogrel | 11 | $109 | $10 |
| Metoprolol | 12 | $101 | $8 |
| Fluoxetine | 13 | $98 | $8 |
| Trazodone | 13 | $98 | $8 |
2015: 75 drugs
| Letairis | 13 | $96,563 | $7,428 |
| Spiriva | 96 | $34,431 | $359 |
| Advair Diskus | 84 | $28,057 | $334 |
| Lantus | 43 | $15,546 | $362 |
| Lyrica | 49 | $11,159 | $228 |
| Erythrocin Stearate | 34 | $8,074 | $237 |
| Vancomycin | 66 | $7,418 | $112 |
| Victoza 3-Pak | 21 | $7,147 | $340 |
| Novolin R | 49 | $6,568 | $134 |
| Budesonide | 11 | $5,090 | $463 |
| Namenda Xr | 30 | $5,048 | $168 |
| Spiriva Respimat | 15 | $4,790 | $319 |
| Carafate | 13 | $4,137 | $318 |
| Nexium | 27 | $3,520 | $130 |
| Daliresp | 13 | $3,384 | $260 |
| Meropenem | 14 | $3,240 | $231 |
| Dulera | 12 | $3,156 | $263 |
| Heparin | 101 | $2,801 | $28 |
| Baclofen | 72 | $2,586 | $36 |
| Piperacillin-Tazobactam | 11 | $2,425 | $220 |
| Fenofibrate | 43 | $2,351 | $55 |
| Omega-3 Acid Ethyl Esters | 16 | $2,292 | $143 |
| Midodrine | 16 | $2,262 | $141 |
| Pravastatin | 62 | $2,086 | $34 |
| Crestor | 19 | $2,077 | $109 |
| Proair Hfa | 27 | $1,984 | $73 |
| Carbidopa-Levodopa | 50 | $1,873 | $37 |
| Fenofibrate | 17 | $1,822 | $107 |
| Famotidine | 55 | $1,661 | $30 |
| Memantine | 21 | $1,608 | $77 |
| Gabapentin | 46 | $1,580 | $34 |
| Gemfibrozil | 60 | $1,508 | $25 |
| Ipratropium-Albuterol | 69 | $1,499 | $22 |
| Metformin | 82 | $1,344 | $16 |
| Fentanyl | 21 | $1,289 | $61 |
| Atropine Sulfate | 27 | $1,282 | $47 |
| Azithromycin | 76 | $1,258 | $17 |
| Hydroxychloroquine Sulfate | 12 | $1,221 | $102 |
| Lactulose | 21 | $1,139 | $54 |
| Montelukast | 45 | $1,013 | $23 |
| Potassium Chloride | 12 | $967 | $81 |
| Nitrofurantoin | 20 | $791 | $40 |
| Methadone | 64 | $764 | $12 |
| Sodium Chloride | 18 | $751 | $42 |
| Bethanechol Chloride | 12 | $683 | $57 |
| Tamsulosin | 19 | $668 | $35 |
| Levothyroxine | 42 | $663 | $16 |
| Prednisone | 59 | $651 | $11 |
| Levetiracetam | 29 | $639 | $22 |
| Atorvastatin | 29 | $600 | $21 |
| Lisinopril | 58 | $591 | $10 |
| Levofloxacin | 20 | $552 | $28 |
| Glyburide | 14 | $494 | $35 |
| Metoclopramide | 36 | $485 | $13 |
| Carvedilol | 34 | $474 | $14 |
| Glipizide | 47 | $469 | $10 |
| Amiodarone | 25 | $398 | $16 |
| Ondansetron | 11 | $370 | $34 |
| Nitroglycerin Patch | 12 | $360 | $30 |
| Donepezil | 14 | $354 | $25 |
| Amlodipine Besylate | 32 | $324 | $10 |
| Terazosin | 17 | $313 | $18 |
| Benztropine Mesylate | 13 | $273 | $21 |
| Fluticasone Propionate | 17 | $252 | $15 |
| Simvastatin | 12 | $233 | $19 |
| Hydrocodone-Acetaminophen | 12 | $214 | $18 |
| Spironolactone | 12 | $166 | $14 |
| Clonidine | 12 | $166 | $14 |
| Metoprolol | 20 | $164 | $8 |
| Topiramate | 11 | $159 | $14 |
| Clopidogrel | 13 | $136 | $10 |
| Brimonidine | 11 | $126 | $11 |
| Furosemide | 14 | $88 | $6 |
| Zolpidem | 14 | $87 | $6 |
| Fluoxetine | 11 | $83 | $8 |
2014: 72 drugs
| Letairis | 13 | $93,755 | $7,212 |
| Spiriva | 143 | $50,141 | $351 |
| Advair Diskus | 131 | $40,275 | $307 |
| Modafinil | 25 | $16,920 | $677 |
| Lantus | 39 | $9,495 | $243 |
| Namenda Xr | 39 | $7,432 | $191 |
| Erythrocin Stearate | 12 | $6,577 | $548 |
| Piperacillin-Tazobactam | 28 | $6,136 | $219 |
| Lyrica | 30 | $5,842 | $195 |
| Flovent Hfa | 21 | $5,383 | $256 |
| Namenda | 32 | $4,522 | $141 |
| Novolin R | 38 | $4,229 | $111 |
| Symbicort | 14 | $3,899 | $279 |
| Nexium | 25 | $3,044 | $122 |
| Heparin | 95 | $3,013 | $32 |
| Pravastatin | 68 | $2,849 | $42 |
| Proair Hfa | 36 | $2,375 | $66 |
| Dextrose in Water | 26 | $2,251 | $87 |
| Lovaza | 22 | $2,008 | $91 |
| Carafate | 15 | $1,949 | $130 |
| Omega-3 Acid Ethyl Esters | 15 | $1,941 | $129 |
| Enoxaparin | 11 | $1,884 | $171 |
| Levetiracetam | 27 | $1,834 | $68 |
| Vancomycin | 36 | $1,772 | $49 |
| Gemfibrozil | 47 | $1,711 | $36 |
| Metformin | 57 | $1,503 | $26 |
| Montelukast | 51 | $1,441 | $28 |
| Donepezil | 18 | $1,344 | $75 |
| Azithromycin | 80 | $1,127 | $14 |
| Baclofen | 50 | $1,095 | $22 |
| Bystolic | 23 | $1,030 | $45 |
| Fenofibrate | 14 | $1,026 | $73 |
| Carbidopa-Levodopa | 34 | $996 | $29 |
| Famotidine | 38 | $940 | $25 |
| Lactulose | 24 | $918 | $38 |
| Ipratropium-Albuterol | 36 | $847 | $24 |
| Fentanyl | 17 | $836 | $49 |
| Ethambutol | 12 | $821 | $68 |
| Potassium Chloride | 22 | $818 | $37 |
| Hydrocodone-Acetaminophen | 26 | $752 | $29 |
| Levothyroxine | 42 | $693 | $16 |
| Methadone | 83 | $682 | $8 |
| Amiodarone | 25 | $670 | $27 |
| Amlodipine Besylate | 65 | $636 | $10 |
| Nystatin | 21 | $623 | $30 |
| Prednisone | 63 | $594 | $9 |
| Glipizide | 39 | $515 | $13 |
| Atorvastatin | 32 | $515 | $16 |
| Sodium Chloride | 12 | $506 | $42 |
| Gabapentin | 29 | $438 | $15 |
| Carvedilol | 28 | $392 | $14 |
| Fluticasone Propionate | 16 | $388 | $24 |
| Lisinopril | 39 | $377 | $10 |
| Nitrofurantoin | 14 | $352 | $25 |
| Megestrol Acetate | 12 | $350 | $29 |
| Nitroglycerin Patch | 11 | $330 | $30 |
| Simvastatin | 16 | $287 | $18 |
| Hydroxychloroquine Sulfate | 12 | $268 | $22 |
| Omeprazole | 21 | $267 | $13 |
| Metoclopramide | 19 | $211 | $11 |
| Levofloxacin | 12 | $196 | $16 |
| Spironolactone | 13 | $174 | $13 |
| Metoprolol | 21 | $165 | $8 |
| Furosemide | 21 | $161 | $8 |
| Clopidogrel | 12 | $150 | $13 |
| Brimonidine | 13 | $149 | $11 |
| Pramipexole Dihydrochloride | 14 | $149 | $11 |
| Zolpidem | 15 | $149 | $10 |
| Clonidine | 11 | $146 | $13 |
| Warfarin | 12 | $106 | $9 |
| Fluoxetine | 12 | $91 | $8 |
| Allopurinol | 11 | $45 | $4 |
2013: 52 drugs
| Spiriva | 162 | $52,394 | $323 |
| Advair Diskus | 83 | $22,162 | $267 |
| Enoxaparin | 36 | $6,414 | $178 |
| Symbicort | 25 | $5,955 | $238 |
| Lantus | 29 | $4,867 | $168 |
| Erythrocin Stearate | 16 | $4,056 | $254 |
| Nexium | 26 | $2,961 | $114 |
| Meropenem | 16 | $2,328 | $145 |
| Lyrica | 13 | $2,146 | $165 |
| Heparin | 78 | $2,128 | $27 |
| Proair Hfa | 33 | $2,110 | $64 |
| Daliresp | 11 | $2,094 | $190 |
| Novolin R | 21 | $1,932 | $92 |
| Ipratropium-Albuterol | 75 | $1,854 | $25 |
| Humalog | 11 | $1,731 | $157 |
| Montelukast | 35 | $1,652 | $47 |
| Pravastatin | 51 | $1,114 | $22 |
| Nystatin | 30 | $1,057 | $35 |
| Fentanyl | 12 | $921 | $77 |
| Bystolic | 23 | $917 | $40 |
| Azithromycin | 45 | $672 | $15 |
| Hydrocodone-Acetaminophen | 33 | $666 | $20 |
| Amiodarone | 24 | $628 | $26 |
| Famotidine | 50 | $616 | $12 |
| Sodium Chloride | 19 | $589 | $31 |
| Levofloxacin | 14 | $575 | $41 |
| Glycopyrrolate | 13 | $540 | $42 |
| Atorvastatin | 22 | $508 | $23 |
| Amlodipine Besylate | 61 | $503 | $8 |
| Potassium Chloride | 30 | $486 | $16 |
| Prednisone | 59 | $427 | $7 |
| Methadone | 55 | $420 | $8 |
| Omeprazole | 27 | $412 | $15 |
| Gabapentin | 24 | $390 | $16 |
| Metformin | 26 | $331 | $13 |
| Zolpidem | 39 | $284 | $7 |
| Hydrocortisone | 11 | $279 | $25 |
| Megestrol Acetate | 12 | $278 | $23 |
| Lisinopril | 32 | $274 | $9 |
| Levothyroxine | 19 | $250 | $13 |
| Donepezil | 14 | $250 | $18 |
| Hydroxyzine | 11 | $249 | $23 |
| Pramipexole Dihydrochloride | 11 | $243 | $22 |
| Metoclopramide | 20 | $235 | $12 |
| Glipizide | 27 | $220 | $8 |
| Baclofen | 23 | $200 | $9 |
| Simvastatin | 15 | $148 | $10 |
| Carvedilol | 12 | $138 | $11 |
| Furosemide | 24 | $131 | $5 |
| Spironolactone | 11 | $104 | $9 |
| Ranitidine | 11 | $90 | $8 |
| Mirtazapine | 11 | $88 | $8 |
Money from drug and device companies
$804 in 2025
| 2025 | 9 | 25 | None | $804 |
| 2024 | 5 | 14 | None | $618 |
| 2023 | 6 | 24 | $3,000 | $13,179 |
| 2022 | 3 | 10 | None | $690 |
| 2021 | 5 | 8 | None | $626 |
| 2020 | 2 | 3 | None | $174 |
| 2019 | 10 | 17 | None | $1,654 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Insmed | Arikayce | $170 | 15 payments
|
| Verona Pharma | Ohtuvayre | $153 | 3 payments
|
| Stryker | Neptune | $149 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $125 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | None | $124 | 1 payment
|
| Lilly USA | Zepbound | $28 | 1 payment
|
See all 25 published payments
| Insmed | Meals · 2025-12-19 | Arikayce | $31 |
| Insmed | Meals · 2025-11-14 | Arikayce | $15 |
| Insmed | Meals · 2025-10-22 | Arikayce | $15 |
| Intuitive Surgical | Meals · 2025-10-14 | Da Vinci Surgical System | $11 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-25 | None | $124 |
| Insmed | Meals · 2025-09-23 | Arikayce | $8 |
| Verona Pharma | Meals · 2025-09-18 | Ohtuvayre | $2 |
| Verona Pharma | Meals · 2025-09-18 | Ohtuvayre | $25 |
| Inspire Medical Systems | Meals · 2025-09-10 | Inspire | $24 |
| Insmed | Meals · 2025-08-21 | Arikayce | $7 |
| Insmed | Meals · 2025-08-08 | Arikayce | $8 |
| Insmed | Meals · 2025-07-01 | Arikayce | $6 |
| Stryker | Meals · 2025-06-13 | Neptune | $149 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-29 | Fasenra | $22 |
| Insmed | Meals · 2025-05-23 | Arikayce | $10 |
| Verona Pharma | Meals · 2025-05-15 | Ohtuvayre | $125 |
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $125 |
| Insmed | Meals · 2025-05-07 | Arikayce | $19 |
| Lilly USA | Meals · 2025-05-01 | Zepbound | $28 |
| Insmed | Meals · 2025-03-17 | Arikayce | $2 |
| Insmed | Meals · 2025-03-17 | Arikayce | $5 |
| Insmed | Meals · 2025-02-14 | Arikayce | $16 |
| Insmed | Meals · 2025-01-23 | Arikayce | $10 |
| Insmed | Meals · 2025-01-16 | Arikayce | $17 |
| Insmed | Education · 2025-01-16 | Arikayce | $1 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $618
| GlaxoSmithKline | Arexvy | $189 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $159 | 3 payments
|
| Lexicon Pharmaceuticals | Inpefa | $124 | 1 payment
|
| Novo Nordisk | None | $119 | 1 payment
|
| Insmed | Arikayce | $28 | 1 payment
|
2023: $13,179
| Intuitive Surgical | Da Vinci Surgical System | $12,258 | 10 payments
|
| Merit Medical Systems | Aero Stent and Delivery System | $288 | 3 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $203 | 8 payments
|
| La Jolla Pharmaceutical | Giapreza | $187 | 1 payment
|
| AbbVie | Qulipta | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $117 | 1 payment
|
2022: $690
| AstraZeneca Pharmaceuticals LP | Farxiga | $368 | 5 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $277 | 4 payments
|
| Harmony Biosciences | Wakix | $45 | 1 payment
|
2021: $626
| Novo Nordisk | Rybelsus | $238 | 2 payments
|
| Medtronic | Illumisite | $174 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $125 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $77 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $13 | 1 payment
|
2020: $174
| Janssen Pharmaceuticals | Xarelto | $152 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $22 | 1 payment
|
2019: $1,654
| Veran Medical Technologies | Spin | $819 | 6 payments
|
| Amarin Pharma | Vascepa | $259 | 2 payments
|
| Allergan | Avycaz | $137 | 1 payment
|
| Portola Pharmaceuticals | Andexxa | $125 | 1 payment
|
| Novo Nordisk | Tresiba | $121 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $119 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $29 | 2 payments
|
| Relypsa | Veltassa | $21 | 1 payment
|
| Gilead Sciences | None | $13 | 1 payment
|
| Merck Sharp & Dohme | Zerbaxa | $13 | 1 payment
|
Checkups this office reported
5 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 100%That's most of the people this applied to. | 770 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 100%That's most of the people this applied to. | 920 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 3,750 |
| Sleep Apnea: Assessment of Adherence to Positive Airway Pressure TherapyAs Medicare defines this measure | 100% | 492 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 920 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1144312125
- Licence
- CA A70405California A70405: Current · expires 2027-12-31
- Trained
- Georgetown University School of Medicine, 1998
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 105 N Bascom Ave Ste 202, San Jose, CA, 95128
- NPI first listed
- 2006-09-28
- NPI last updated
- 2012-03-26
This is when the NPI record was last certified, not a medical board exam.